| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| REPLIGEN CORP | Senior VP, R&D | Common Stock | 16,062 | $2,495,714 | $155.38 | 03 Mar 2025 | Direct |
| REPLIGEN CORP | Senior VP, R&D | Stock Option (Right to Buy) | 4,542 | 03 Mar 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| RGEN | REPLIGEN CORP | 03 Mar 2025 | 3 | -$59,977 | 4 | Senior VP, R&D | 04 Mar 2025, 13:41 |
| RGEN | REPLIGEN CORP | 27 Feb 2025 | 1 | -$61,207 | 4 | Senior VP, R&D | 28 Feb 2025, 16:28 |
| RGEN | REPLIGEN CORP | 24 Feb 2025 | 1 | -$45,304 | 4 | Senior VP, R&D | 25 Feb 2025, 10:28 |
| RGEN | REPLIGEN CORP | 02 Aug 2024 | 4 | -$1,123,949 | 4 | Senior VP, R&D | 05 Aug 2024, 21:56 |
| RGEN | REPLIGEN CORP | 01 Aug 2024 | 1 | -$739,717 | 4 | Senior VP, R&D | 01 Aug 2024, 20:47 |
| RGEN | REPLIGEN CORP | 14 May 2024 | 1 | -$87,224 | 4 | Senior VP, R&D | 15 May 2024, 20:17 |
| RGEN | REPLIGEN CORP | 11 Mar 2024 | 3 | -$571,915 | 4 | Senior VP, R&D | 12 Mar 2024, 20:24 |
| RGEN | REPLIGEN CORP | 07 Mar 2024 | 1 | -$75,548 | 4 | Senior VP, R&D | 07 Mar 2024, 16:27 |
| RGEN | REPLIGEN CORP | 04 Mar 2024 | 1 | -$26,189 | 4 | Senior VP, R&D | 06 Mar 2024, 20:01 |
| RGEN | REPLIGEN CORP | 29 Feb 2024 | 2 | -$86,881 | 4 | Senior VP, R&D | 04 Mar 2024, 21:51 |
| RGEN | REPLIGEN CORP | 27 Feb 2024 | 2 | $0 | 4 | Senior VP, R&D | 29 Feb 2024, 20:54 |
| RGEN | REPLIGEN CORP | 16 May 2023 | 1 | -$109,361 | 4 | Senior VP, R&D | 16 May 2023, 19:01 |
| RGEN | REPLIGEN CORP | 02 Mar 2023 | 4 | -$234,436 | 4 | Senior VP, R&D | 06 Mar 2023, 16:31 |
| RGEN | REPLIGEN CORP | 28 Feb 2023 | 1 | -$62,034 | 4 | Senior VP, R&D | 01 Mar 2023, 16:32 |
| RGEN | REPLIGEN CORP | 28 Feb 2023 | 1 | -$79,436 | 4 | Senior VP, R&D | 28 Feb 2023, 18:46 |
| RGEN | REPLIGEN CORP | 11 Aug 2022 | 8 | -$1,028,575 | 4 | Senior VP, R&D | 12 Aug 2022, 16:49 |
| RGEN | REPLIGEN CORP | 13 May 2022 | 1 | -$107,085 | 4 | Senior VP, R&D | 17 May 2022, 17:00 |
| RGEN | REPLIGEN CORP | 27 Feb 2022 | 4 | -$498,438 | 4 | Senior VP, R&D | 02 Mar 2022, 19:19 |
| RGEN | REPLIGEN CORP | 24 Feb 2022 | 3 | -$35,571 | 4 | Senior VP, R&D | 28 Feb 2022, 18:10 |
| RGEN | REPLIGEN CORP | 17 Feb 2022 | 2 | -$31,924 | 4 | Senior VP, R&D | 22 Feb 2022, 18:34 |
| RGEN | REPLIGEN CORP | 14 Dec 2021 | 1 | -$112,376 | 4 | Senior VP, R&D | 15 Dec 2021, 20:30 |
| RGEN | REPLIGEN CORP | 30 Aug 2021 | 1 | -$1,128,802 | 4 | Senior VP, R&D | 02 Sep 2021, 06:54 |
| RGEN | REPLIGEN CORP | 10 Jun 2021 | 5 | -$1,044,703 | 4 | Senior VP, R&D | 14 Jun 2021, 18:48 |
| RGEN | REPLIGEN CORP | 14 May 2021 | 1 | -$122,326 | 4 | Senior VP, R&D | 18 May 2021, 07:50 |